Kakizaki et al of age should be refrained from unless symptoms such as dacryocystitis or severe blepharitis are presented. Probing is well tolerated from 13th months of age, according to our result. In conclusion, we have shown that 82.9% of Japanese CNLDO infant patients resolved with just conservative management before their 1st year of age. Since the resolution of CNLDO by conservative management also often occurs between 6 months and the 1st year of age, a “wait and see” policy while implementing conservative management is very useful for CNLDO in Japanese infants. Disclosure The authors have no ﬁnancial interest related to this manu- script. References Broggi RJ. 1959. The treatment of congenital dacryostenosis. Arch Ophthalmol, 61:30–6. Crigler LW. 1923. The treatment of congenital dacryocystitis. JAMA, 81:23–4. Foster JA, Katowitz JA, Heyman S. 1996. Results of dacryoscintigraphy in massage of the congenitally blocked nasolacrimal duct. Ophthal Plast Reconstr Surg, 12:32–7. Honavar SG, Prakash VE, Rao GN. 2000. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol, 130:42–8. Ishikawa C, Tanaka H, Toibana M. 1990. Early probing for congenital nasolacrimal duct obstruction. Folia Ophthalmol Jpn, 41:940–4 (Japanese). Kapadia MK, Freitag SK, Woog JJ. 2006. Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am, 39:959–77. Kashkouli MB, Kassaee A, Tabatabaee Z. 2002. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J AAPOS, 6:360–3. Katowitz JA, Welsh MG. 1987. Timing of initial probing and irriga- tion in congenital nasolacrimal duct obstruction. Ophthalmology, 94:698–705. Kushner BJ. 1982. Congenital nasolacrimal system obstruction. Arch Ophthalmol, 100:597–600. Lyon DB, Dortzbach RK, Lemke BN, et al. 1991. Canalicular stenosis following probing for congenital nasolacrimal duct obstruction. Ophthalmic Surg, 22:228–32. MacEwen CJ, Young JD. 1991a. The ﬂuorescein disappearance test (FDT): an evaluation of its use in infants. J Pediatr Ophthalmol Strabismus, 28:302–5. MacEwen CJ, Young JD. 1991b. Epiphora during the ﬁrst year of life. Eye, 5:596–600. MacEwen CJ, Phillips MG, Young JD. 1994. Value of bacterial culturing in the course of congenital nasolacrimal duct (NLD) obstruction. J Pediatr Ophthalmol Strabismus, 31:246–50. Mannor GE, Rose GE, Frimpong-Ansah K, et al. 1999. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction. Am J Ophthalmol, 127:616–17. Nelson LR, Calhoun JH, Menduke H. 1985. Medical management of con- genital nasolacrimal duct obstruction. Ophthalmology, 92:1187–90. Noda S, Hayasaka S, Setogawa T. 1991. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with mas- sage. J Pediatr Ophthalmol Strabismus, 28:20–2. Nucci P, Capoferri C, Alfarano R, et al. 1989. Conservative management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus, 26:39–43. Ohki R, Yamazaki M. 1993. Diagnosis and treatment of dacryocystitis neonatorum-New probing implement for nasolacrimal duct obstruction in newborns. Jpn J Ophthal Surg, 6:407–12 (Japanese). Paul TO. 1985. Medical management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus, 22:68–70. Petersen RA, Robb RM. 1978. The natural course of congenital obstruc- tion of the nasolacrimal duct. J Pediatr Ophthalmol Strabismus, 15:246–50. Piest KL, Katowitz JA. 1991. Traetment of congenital nasolactrimal duct obstruction. Ophthalmol Clin North Am, 4:201–9. Price HW. 1947. Dacryostenosis. J Pediatr, 30:302–5. Saito M, Hashimoto T, Yago K. 1999. Outcome of congenital nasolacrimal duct obstruction. Gankarinshouihou, 93:92–5 (Japanese). Schellini SA, Capanema S, Ribeiro F, et al. 2007. Spontaneous resolution in congenital nasolacrimal obstruction after 12 months. Semin Ophthalmol, 22:71–4. Takagi I, Emori A, Sengoku A. 2005. Treatment of protracted obstruction of congenital nasolacrimal duct. A step towards therapeutic guidelines based on CT dacryocystography. Jpn J Clin Ophthalmol, 59:851–5 (Japanese). Young JD, MacEwen CJ. 1997. Managing congenital lacrimal obstruction in general practice. BMJ, 315:293–96. Zwaan J. 1997. Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year. Ophthalmic Surg Lasers, 28:932–6. 294 Clinical Ophthalmology 2008:2(2)